DS
CALA

DRW Securities’s Calithera Biosciences, Inc CALA Stock Holding History

DRW Securities’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,062
Closed -$85K – 115
2018
Q4 		$85K Buy
+1,062
New +$105K ﹤0.01% 64

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DRW Securities's CALA Position: Q1 2019 in Review

DRW Securities sold out of Calithera Biosciences, Inc (CALA) in Q1 2019, closing a stake of 1,062 shares — an estimated $85K sold.

DRW Securities first reported a position in CALA in Q4 2018 and held it in 1 quarter. The position peaked at $85K in Q4 2018. 71 funds tracked by Wall St. Rank hold CALA as of Q1 2019.

  • DRW Securities reported no remaining Calithera Biosciences, Inc position as of Q1 2019 after selling out during the quarter.
  • DRW Securities sold 1,062 Calithera Biosciences, Inc shares in Q1 2019, an estimated $85K.
  • DRW Securities first reported a position in Calithera Biosciences, Inc in Q4 2018 and held it in 1 quarter.
  • DRW Securities's Calithera Biosciences, Inc position peaked at $85K in Q4 2018.
  • 71 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2019.

Based on DRW Securities's 13F filing for Q1 2019, filed 15 May 2019.